CONVERTIBLE INVESTMENT INSTRUMENT AGREEMENTConvertible Investment Instrument Agreement • February 14th, 2022 • Morningside Venture Investments LTD • Biological products, (no disgnostic substances) • Delaware
This Convertible Investment Instrument Agreement (“Agreement”) is dated as of December 21, 2021 by and among GreenLight Biosciences, Inc., a Delaware corporation (the “Company”) and the individuals and entities who become parties to this Agreement by executing and delivering an Agreement Signature Page in the form of Exhibit A hereto in accordance with Section 2 hereof (each a “Purchaser” and, collectively, the “Purchasers”).
GREENLIGHT BIOSCIENCES, INC. ENVIRONMENTAL IMPACT ACQUISITION CORP.Subscription Agreement • February 14th, 2022 • Morningside Venture Investments LTD • Biological products, (no disgnostic substances)
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Morningside Venture Investments LTD • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13D (including amendments thereto) jointly on behalf of each such party.
